Dark Forest Capital Management LP Ultragenyx Pharmaceutical Inc. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $10,389 - $17,196	260 New	260 $11,000
Q1 2022 May 13, 2022	SELL	$62.2 - $84.4 $3,980 - $5,401	-64 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$73.71 - $87.86 $4,717 - $5,623	64 New	64 $5,000
Q3 2021 Nov 12, 2021	SELL	$77.92 - $102.4 $28,830 - $37,888	-370 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $34,110 - $42,812	370 New	370 $35,000

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.